Generation 2 Dual agonist (GLP-1 + GIP): Tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight loss) targets two receptors: GLP-1 and GIP
Genetic variants associated with Lp(a) lipoprotein level and coronary disease
Large eligible population: With millions of adults meeting the clinical criteria for obesity, insurers fear a financial tidal wave that threatens to overwhelm their budgets and destabilize premium costs
You have a history of any hormone-sensitive condition, or active cancer Neither is appropriate without specialist evaluation
Quercetin represses cholesterol metabolism and mitigates resistance to cisplatin in oral squamous cell carcinoma by regulating AGR2/AKT/SREBP2 axis
Pandya JD, Leung LY, Yang X, Flerlage WJ, Gilsdorf JS, Deng-Bryant Y, et al